Spectral AI, Inc. (NASDAQ: MDAI) Stock Competitors & Peer Comparison
See MDAI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDAI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDAI | $1.66 | +5.06% | 52.8M | -3.69 | -$0.45 | N/A |
| ALC | $64.75 | -1.05% | 31.6B | 20.36 | $3.18 | +0.55% |
| STE | $210.01 | -0.30% | 20.5B | 20.17 | $10.42 | +1.22% |
| MLAB | $129.94 | -0.79% | 727.1M | 13.11 | $9.91 | +0.49% |
| QDEL | $10.54 | -0.52% | 718.7M | 7.87 | $1.34 | N/A |
| BWAY | $13.20 | -2.08% | 517.7M | 33.53 | $0.39 | N/A |
| MASS | $12.34 | +4.14% | 506.3M | -20.57 | -$0.60 | N/A |
| SI | $18.90 | +0.59% | 392M | -10.92 | -$1.73 | N/A |
| MOBI | $9.45 | +4.77% | 314.2M | -4.90 | -$1.93 | N/A |
| LAB | $0.74 | +3.83% | 289.9M | -10.58 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
MDAI vs ALC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, ALC has a market cap of 31.6B. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while ALC trades at $64.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas ALC's P/E ratio is 20.36. In terms of profitability, MDAI's ROE is +1.21%, compared to ALC's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ALC's competition here
STERIS plc (NYSE: STE)
MDAI vs STE Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while STE trades at $210.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas STE's P/E ratio is 20.17. In terms of profitability, MDAI's ROE is +1.21%, compared to STE's ROE of +0.11%. Regarding short-term risk, MDAI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
MDAI vs MLAB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, MLAB has a market cap of 727.1M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while MLAB trades at $129.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas MLAB's P/E ratio is 13.11. In terms of profitability, MDAI's ROE is +1.21%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, MDAI is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MDAI vs QDEL Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, QDEL has a market cap of 718.7M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while QDEL trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas QDEL's P/E ratio is 7.87. In terms of profitability, MDAI's ROE is +1.21%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MDAI is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
MDAI vs BWAY Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, BWAY has a market cap of 517.7M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while BWAY trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas BWAY's P/E ratio is 33.53. In terms of profitability, MDAI's ROE is +1.21%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, MDAI is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
MDAI vs MASS Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, MASS has a market cap of 506.3M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while MASS trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas MASS's P/E ratio is -20.57. In terms of profitability, MDAI's ROE is +1.21%, compared to MASS's ROE of -0.25%. Regarding short-term risk, MDAI is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
MDAI vs SI Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, SI has a market cap of 392M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while SI trades at $18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas SI's P/E ratio is -10.92. In terms of profitability, MDAI's ROE is +1.21%, compared to SI's ROE of -0.26%. Regarding short-term risk, MDAI is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
MDAI vs MOBI Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, MOBI has a market cap of 314.2M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while MOBI trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas MOBI's P/E ratio is -4.90. In terms of profitability, MDAI's ROE is +1.21%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, MDAI is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
MDAI vs LAB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, LAB has a market cap of 289.9M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while LAB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas LAB's P/E ratio is -10.58. In terms of profitability, MDAI's ROE is +1.21%, compared to LAB's ROE of -0.18%. Regarding short-term risk, MDAI is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
MDAI vs ANIK Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, ANIK has a market cap of 263.1M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while ANIK trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas ANIK's P/E ratio is 40.12. In terms of profitability, MDAI's ROE is +1.21%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, MDAI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
MDAI vs EDAP Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MDAI's ROE is +1.21%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, MDAI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
MDAI vs NYXH Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, NYXH has a market cap of 138.1M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while NYXH trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas NYXH's P/E ratio is -0.55. In terms of profitability, MDAI's ROE is +1.21%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MDAI is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
MDAI vs TRIB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, TRIB has a market cap of 130.2M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while TRIB trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas TRIB's P/E ratio is -0.11. In terms of profitability, MDAI's ROE is +1.21%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, MDAI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
MDAI vs APYX Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, APYX has a market cap of 105.5M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while APYX trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas APYX's P/E ratio is -12.52. In terms of profitability, MDAI's ROE is +1.21%, compared to APYX's ROE of -0.79%. Regarding short-term risk, MDAI is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
MDAI vs SKIN Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, SKIN has a market cap of 81.6M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while SKIN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas SKIN's P/E ratio is -2.86. In terms of profitability, MDAI's ROE is +1.21%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, MDAI is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
MDAI vs DRIO Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, DRIO has a market cap of 51.5M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while DRIO trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas DRIO's P/E ratio is -1.20. In terms of profitability, MDAI's ROE is +1.21%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, MDAI is more volatile compared to DRIO. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
MDAI vs BEAT Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, BEAT has a market cap of 20.3M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas BEAT's P/E ratio is -0.72. In terms of profitability, MDAI's ROE is +1.21%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, MDAI is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
MDAI vs MDAIW Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, MDAIW has a market cap of 15.1M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while MDAIW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas MDAIW's P/E ratio is -1.34. In terms of profitability, MDAI's ROE is +1.21%, compared to MDAIW's ROE of N/A. Regarding short-term risk, MDAI is more volatile compared to MDAIW. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MDAI vs BEATW Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, BEATW has a market cap of 4.3M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas BEATW's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, MDAI is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
MDAI vs WOK Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, WOK has a market cap of 4.3M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while WOK trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas WOK's P/E ratio is N/A. In terms of profitability, MDAI's ROE is +1.21%, compared to WOK's ROE of -0.19%. Regarding short-term risk, MDAI is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for MDAI.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
MDAI vs QTEXW Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MDAI's ROE is +1.21%, compared to QTEXW's ROE of N/A. Regarding short-term risk, MDAI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
MDAI vs ITOC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas ITOC's P/E ratio is -0.90. In terms of profitability, MDAI's ROE is +1.21%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MDAI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
MDAI vs FEED Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas FEED's P/E ratio is -0.15. In terms of profitability, MDAI's ROE is +1.21%, compared to FEED's ROE of -0.60%. Regarding short-term risk, MDAI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
MDAI vs TIVC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAI stands at 52.8M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, MDAI is priced at $1.66 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAI currently has a P/E ratio of -3.69, whereas TIVC's P/E ratio is -0.04. In terms of profitability, MDAI's ROE is +1.21%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, MDAI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for MDAI.Check TIVC's competition here